CoreRx Inc. has agreed to acquire Societal CDMO, Inc., a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, in a deal valued at approximately $130 million.

To learn more, please check out this article from Contract Pharma.

Leave a Reply

Your email address will not be published. Required fields are marked *